| Donald L Milholland, CRNA | |
|
2700 152nd Ave Ne, Redmond, WA 98052-5543 | |
| (425) 883-5151 | |
| Not Available |
| Full Name | Donald L Milholland |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 2700 152nd Ave Ne, Redmond, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346375334 | NPI | - | NPPES |
| 9623612 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN00049232 (Washington) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | AP30000142 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Donald L Milholland, CRNA Po Box 34584, Seattle, WA 98124-1584 Ph: (509) 241-7349 | Donald L Milholland, CRNA 2700 152nd Ave Ne, Redmond, WA 98052-5543 Ph: (425) 883-5151 |
News Archive
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced it has signed an agreement with Roche for the development of novel antibody therapeutics.
A recent report from the U.S. surgeon general on bone health and osteoporosis has found that black women have a lower risk of fracture than white women at every level of bone mineral density.
The University of Texas MD Anderson Cancer Center and Sanofi today announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer.
Cancers are due to genetic aberrations in certain cells that gain the ability to divide indefinitely. This proliferation of sick cells generates tumors, which gradually invade healthy tissue. Therefore, current therapies essentially seek to destroy cancer cells to stop their proliferation. Through high-throughput genetic sequencing of glioblastoma cells, one of the most deadly brain tumors, a team of geneticists from the University of Geneva's (UNIGE) Faculty of Medicine discovered that some of these mutations are caused by supplemental extrachromosomal DNA fragments, called double minutes, which enable cancer cells to better adapt to their environment and therefore better resist to treatments meant to destroy them.
› Verified 6 days ago
Karen Purcell, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-883-5151 | |
Jane E Snatic, ARNP Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-883-5151 | |
Constance H Davidson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-838-5151 | |
Mriana Williams, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-838-5151 | |
Jewel N Hagen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-883-5151 | |
Beth Kristenson,, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-883-5151 |